Imoh Lucius C, Longwap Abdulazis S, Haruna Favour E, Asieba Oghale J, Istifanus Joy P, Imoh Joy A, Banwat Mathilda E
Department of Chemical Pathology, Faculty of Medical Sciences, University of Jos, Jos, Plateau State, Nigeria.
Department of Geography and Planning, Faculty of Environmental Science, University of Jos, Jos, Plateau State, Nigeria.
Afr J Lab Med. 2022 Oct 31;11(1):1845. doi: 10.4102/ajlm.v11i1.1845. eCollection 2022.
Screening for hyperglycaemia in pregnancy (HIP) is an important component of comprehensive antenatal care. Screening practices for HIP in Nigeria and factors that influence these practices are not well understood.
We examined the screening practices for HIP and their correlates among antenatal healthcare providers (AHPs).
This descriptive cross-sectional study of AHPs providing all levels of antenatal care was conducted between August 2019 and September 2019 in Jos, Nigeria. Eligible AHPs completed a semi-structured, self-administered questionnaire, and data were analysed for adherence to recommended screening practices such as World Health Organization, International Association of Diabetes and Pregnancy Study Groups and National Institute for Health and Care Excellence guidelines.
Of the 128 respondents included in the analysis, 59 (46.1%) were male and 69 (53.9%) were female. The mean participant age was 35.7 years (standard deviation: ± 8.5 years). Most (68.0%) screened all pregnant women (universal screening) for gestational diabetes mellitus. Fasting blood glucose (77.0%) and random blood glucose (55.7%) were the most common tests used. Only 27 respondents (22.1%) screened using the 75 g oral glucose tolerance test, and most were doctors, AHPs in faith-based or government institutions, tertiary institutions and facilities with availability of automated glucose analysers ( < 0.05 for all).
Screening practices for HIP among the AHPs do not generally conform to best practices. Hence, there is an urgent need for implementation of universal guidelines and provision of regular updates and basic glucose measuring devices for AHPs at all healthcare levels.
孕期高血糖筛查（HIP）是全面产前护理的重要组成部分。尼日利亚的HIP筛查实践以及影响这些实践的因素尚未得到充分了解。
我们研究了产前医疗服务提供者（AHPs）的HIP筛查实践及其相关因素。
2019年8月至2019年9月在尼日利亚乔斯对提供各级产前护理的AHPs进行了这项描述性横断面研究。符合条件的AHPs完成了一份半结构化的自填问卷，并对数据进行分析，以评估是否遵守世界卫生组织、国际糖尿病与妊娠研究组协会以及英国国家卫生与临床优化研究所指南等推荐的筛查实践。
纳入分析的128名受访者中，59名（46.1%）为男性，69名（53.9%）为女性。参与者的平均年龄为35.7岁（标准差：±8.5岁）。大多数（68.0%）对所有孕妇进行妊娠期糖尿病的普遍筛查。空腹血糖（77.0%）和随机血糖（55.7%）是最常用的检测方法。只有27名受访者（22.1%）使用75克口服葡萄糖耐量试验进行筛查，大多数是医生、宗教或政府机构、高等院校以及配备自动血糖分析仪的机构中的AHPs（所有比较均P<0.05）。
AHPs中HIP的筛查实践总体上不符合最佳实践。因此，迫切需要实施通用指南，并为各级医疗保健机构的AHPs定期提供更新内容和基本血糖测量设备。
